James E. Flynn, Ten Percent Owner Other at Terns Pharmaceuticals, Inc. (TERN), bought 2,382,033 shares at $17.00 ($11.3M) on 2021-02-09, disclosed to the SEC on 2021-02-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,717,033 | $0 | 0.0% |
| 2 | $17.00 | 665,000 | $11.3M | 100.0% |
| Total | $4.75 avg | 2,382,033 | $11.3M | 100% |
| Filing → |
| SPRY | SELL | 2025-07-01 | $27.3M | — | Filing → |
| ONCR | SELL | 2022-12-30 | $65K | — | Filing → |
| ONCR | SELL | 2022-12-21 | $23K | — | Filing → |